Congress should consider legislation authorizing agency to conduct enforcement more directly, says Associate Commissioner Schiller. In FDLI conference keynote, he discussed compliance with FDA regulations across markets it regulates, but made specific example of saying FDA is comparatively hamstrung in regulating businesses marketing products labeled as supplements.
The Food and Drug Administration needs authority to regulate dietary supplement manufacturing and marketing more directly and efficiently, says FDA Principal Associate Commissioner Lowell Schiller.
Congress should consider legislation that would authorize the agency with regulatory oversight that eliminates space "for potential bad actors to...